ExlService Holdings, Inc.

EXLS

Held by 2 specialist biotech funds

2 funds opened new positions. Short interest: 7.2% of float.

Share

Signal Score

2.1/10

2 funds opened new positions

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 2 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Driehaus Capital

Eventide Asset Management

Position history (shares)

Driehaus Capital

2Q

Eventide Asset Management

3Q

3 quarters

Position Trend

Aug 14, 2025

$53.9M

2 funds

Nov 14, 2025

$1.8M

1 fund

Feb 13, 2026

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 5 quarters

Short Interest

Short Shares

7.88M

Change

+6.6%

Days to Cover

3.2

% of Float

7.2%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

7 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

EWTX2 funds TMDX2 funds NVDA2 funds VEEV2 funds AXON2 funds RMBS2 funds LITE2 funds UNP2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer